Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Mirum Pharmaceuticals, Inc. (MIRM)

85.74 +0.74 (+0.87%)
At close: 4:00:02 PM EST
85.74 0.00 (0.00%)
After hours: 4:00:13 PM EST
Trade MIRM on Coinbase
MIRM Q3 2026 earnings call
November 3, 2026 at 4:30 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
618,067
521,312
336,888
186,374
77,062
Cost of Revenue
112,954
100,240
81,643
47,039
12,374
Gross Profit
505,113
421,072
255,245
139,335
64,688
Operating Expense
601,342
443,208
342,851
248,489
195,908
Operating Income
-96,229
-22,136
-87,606
-109,154
-131,220
Net Non Operating Interest Income Expense
485
-1,662
-519
-1,370
-12,122
Other Income Expense
-761,794
2,371
1,213
-51,900
1,271
Pretax Income
-857,538
-21,427
-86,912
-162,424
-142,071
Tax Provision
2,669
1,936
1,030
991
-6,406
Net Income Common Stockholders
-860,207
-23,363
-87,942
-163,415
-135,665
Average Dilution Earnings
--
--
0
0
-914
Diluted NI Available to Com Stockholders
-860,207
-23,363
-87,942
-163,415
-136,579
Basic EPS
-14.08
-0.47
-1.85
-3.94
-4.01
Diluted EPS
-14.08
-0.47
-1.85
-3.94
-4.02
Basic Average Shares
56,105.73
50,198.30
47,522.59
40,885.12
33,839.07
Diluted Average Shares
56,105.73
50,198.30
47,522.59
40,885.12
33,982.49
Total Operating Income as Reported
-833,966
-22,136
-87,606
-109,154
-131,220
Total Expenses
714,296
543,448
424,494
295,528
208,282
Net Income from Continuing & Discontinued Operation
-860,207
-23,363
-87,942
-163,415
-135,665
Normalized Income
-417,564.80
-23,363
-87,942
-126,985.89
-136,530.14
Interest Income
13,923
12,727
13,792
13,735
3,857
Interest Expense
13,438
14,389
14,311
15,105
15,979
Net Interest Income
485
-1,662
-519
-1,370
-12,122
EBIT
-844,100
-7,038
-72,601
-147,319
-126,092
EBITDA
-818,154
17,206
-48,972
-136,490
-122,854
Reconciled Cost of Revenue
112,954
100,240
81,643
47,039
12,374
Reconciled Depreciation
25,946
24,244
23,629
10,829
3,238
Net Income from Continuing Operation Net Minority Interest
-860,207
-23,363
-87,942
-163,415
-135,665
Total Unusual Items Excluding Goodwill
-737,737
0
0
-49,076
906
Total Unusual Items
-737,737
0
0
-49,076
906
Normalized EBITDA
-80,417
17,206
-48,972
-87,414
-123,760
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-295,094.80
0
0
-12,646.89
40.86
12/31/2022 - 7/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: